A Phase 1B Clinical Study of Combretastatin A1 Diphosphate (OXi4503) and Cytarabine (ARA-C) in Combination (OXA) for Patients with Relapsed or Refractory Acute Myeloid Leukemia

Overview of attention for article published in Cancers, December 2019

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (97th percentile)
High Attention Score compared to outputs of the same age and source (98th percentile)

Mentioned by

news: 10 news outlets

twitter: 2 X users

Readers on

mendeley: 29 Mendeley

So far, Altmetric has seen 15 news stories from 10 outlets.

Mateon Therapeutics Team Publishes a New Peer-Reviewed Oncology Article on the Positive Clinical Study Results for Its Lead Anti-Leukemia Drug Combretastatin A1 Plus Cytarabine in Adult Patients With Relapsed Acute Myeloid Leukemia

Stockwatch, 27 Dec 2019

AGOURA HILLS, Calif., Dec. 27, 2019 (GLOBE NEWSWIRE) -- Mateon Therapeutics Inc.

Mateon Therapeutics Team Publishes a New Peer-Reviewed Oncology Article on the Positive Clinical Study Results for Its Lead Anti-Leukemia Drug Combretastatin A1 Plus Cytarabine in Adult Patients With Relapsed Acute Myeloid Leukemia

MarketScreener, 27 Dec 2019

AGOURA HILLS, Calif., Dec. 27, 2019 (GLOBE NEWSWIRE) -- Mateon Therapeutics Inc.

Mateon Therapeutics Team Publishes a New Peer-Reviewed Oncology Article on the Positive Clinical Study Results for Its Lead Anti-Leukemia Drug Combretastatin A1 Plus Cytarabine in Adult Patients With Relapsed Acute Myeloid Leukemia

Benzinga, 27 Dec 2019

AGOURA HILLS, Calif., Dec. 27, 2019 (GLOBE NEWSWIRE) -- Mateon Therapeutics Inc.

Mateon Therapeutics Team Publishes a New Peer-Reviewed Oncology Article on the Positive Clinical Study Results for Its Lead Anti-...

EINPresswire, 27 Dec 2019

/ EIN News / -- AGOURA HILLS, Calif., Dec. 27, 2019 (GLOBE NEWSWIRE) -- Mateon Therapeutics Inc.

This page shows the most recent news stories that mention this research output. Click here to find out how to access more activity, including 11 additional news stories.